
Dupilumab and AD: Pediatric Ocular Adverse Effects
Atopic dermatitis (AD) is characterized by a dysregulated T-helper 2 immune response and an impaired epidermal barrier, leading to pruritic skin lesions.1 Dupilumab, a monoclonal antibody that inhibits interleukin (IL)-4 and IL-13 signaling, is the first …